![Qi Ying Lu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Qi Ying Lu currently works at ImmuneOnco Biopharmaceuticals (Shanghai), Inc., as Chief Medical Officer & senior Vice President from 2022.
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC. | Directeur Technique/Scientifique/R&D | 01/03/2022 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 1 |
|---|---|
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd.
 ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a early-stage biopharmaceutical company which develops and commercializes novel cancer immunotherapeutic products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
